Lymphokine-activated killer cell: Difference between revisions
Jump to navigation
Jump to search
m Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +) |
m Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}) |
||
| Line 7: | Line 7: | ||
==References== | ==References== | ||
{{reflist}} | {{reflist|2}} | ||
==External links== | ==External links== | ||
Latest revision as of 19:13, 4 September 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
In cell biology, a lymphokine-activated killer cell (also known as a LAK cell) is a white blood cell that has been stimulated to kill tumour cells.[1] If lymphocytes are cultured in the presence of Interleukin 2, it results in the development of effector cells which are cytotoxic to tumour cells.[2]
References
- ↑ "Definition of lymphokine-activated killer cell". National Cancer Institute. Retrieved 2007-03-06.
- ↑ "Medical Dictionary: Lymphokine-activated killer cell". Wrong Diagnosis. Retrieved 2007-03-06.
External links
- Lymphokine-Activated+Killer+Cells at the US National Library of Medicine Medical Subject Headings (MeSH)